Search research articles
Contact Us
Filters
Showing results (281-290 of 484) with videos related to
Page
of 49
Sort By:
Journal of Cell Science
|
October 29, 2010
Defective granulation tissue formation in mice with specific ablation of integrin-linked kinase in fibroblasts - role of TGFβ1 levels and RhoA activity
Katrin Blumbach, Manon C Zweers, Georg Brunner, et al.
Arthritis and Rheumatism
|
September 2, 2006
Endothelin axis polymorphisms in patients with scleroderma
Carmen Fonseca, Elizabeth Renzoni, Piersante Sestini, et al.
Journal of Scleroderma and Related Disorders
|
June 8, 2026
Influence of comorbidities and patient demographics on Raynaud's symptom characteristics: implications for diagnosis and management
Reshma Seomore, Matthew Wells, Ula Tymoszuk, et al.
Annals of the Rheumatic Diseases
|
May 23, 2012
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database
Florian M P Meier, Klaus W Frommer, Robert Dinser, et al.
Rheumatology (Oxford, England)
|
May 25, 2023
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort
Abeer Ghuman, Dinesh Khanna, Celia J F Lin, et al.
ACR Open Rheumatology
|
March 11, 2025
Comparative Efficacy of Immunosuppressive Therapies in the Treatment of Diffuse Cutaneous Systemic Sclerosis
Barbara White, Daniel E Furst, Tracy M Frech, et al.
Trials
|
June 17, 2017
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
Peter Saunders, Vicky Tsipouri, Gregory J Keir, et al.
Rheumatology (Oxford, England)
|
February 12, 2022
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial
Elizabeth R Volkmann, Michael Kreuter, Anna M Hoffmann-Vold, et al.
The Lancet. Rheumatology
|
January 22, 2024
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine
Alain Lescoat, Silvia Bellando-Randone, Corrado Campochiaro, et al.
Annals of the Rheumatic Diseases
|
July 27, 2016
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2
Marc Humbert, J Gerry Coghlan, Hossein-Ardeschir Ghofrani, et al.
Page
of 49
Search research articles
Search
Showing results (281-290 of 484) with videos related to
Sort By:
Page
of 49
Journal of Cell Science
|
October 29, 2010
Defective granulation tissue formation in mice with specific ablation of integrin-linked kinase in fibroblasts - role of TGFβ1 levels and RhoA activity
Katrin Blumbach, Manon C Zweers, Georg Brunner, et al.
Arthritis and Rheumatism
|
September 2, 2006
Endothelin axis polymorphisms in patients with scleroderma
Carmen Fonseca, Elizabeth Renzoni, Piersante Sestini, et al.
Journal of Scleroderma and Related Disorders
|
June 8, 2026
Influence of comorbidities and patient demographics on Raynaud's symptom characteristics: implications for diagnosis and management
Reshma Seomore, Matthew Wells, Ula Tymoszuk, et al.
Annals of the Rheumatic Diseases
|
May 23, 2012
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database
Florian M P Meier, Klaus W Frommer, Robert Dinser, et al.
Rheumatology (Oxford, England)
|
May 25, 2023
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort
Abeer Ghuman, Dinesh Khanna, Celia J F Lin, et al.
ACR Open Rheumatology
|
March 11, 2025
Comparative Efficacy of Immunosuppressive Therapies in the Treatment of Diffuse Cutaneous Systemic Sclerosis
Barbara White, Daniel E Furst, Tracy M Frech, et al.
Trials
|
June 17, 2017
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
Peter Saunders, Vicky Tsipouri, Gregory J Keir, et al.
Rheumatology (Oxford, England)
|
February 12, 2022
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial
Elizabeth R Volkmann, Michael Kreuter, Anna M Hoffmann-Vold, et al.
The Lancet. Rheumatology
|
January 22, 2024
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine
Alain Lescoat, Silvia Bellando-Randone, Corrado Campochiaro, et al.
Annals of the Rheumatic Diseases
|
July 27, 2016
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2
Marc Humbert, J Gerry Coghlan, Hossein-Ardeschir Ghofrani, et al.
Page
of 49